首页 | 本学科首页   官方微博 | 高级检索  
检索        

非霍奇金淋巴瘤应用CHOP化疗方案的远期疗效观察
引用本文:卫兵,刘宽荣.非霍奇金淋巴瘤应用CHOP化疗方案的远期疗效观察[J].基层医学论坛,2012,16(17):2181-2182.
作者姓名:卫兵  刘宽荣
作者单位:阳城县肿瘤医院,山西,阳城,048100
摘    要:目的观察非霍奇金淋巴瘤(NHL)应用CHOP方案化疗的远期疗效。方法35例非霍奇金淋巴瘤患者接受CHOP方案治疗1-14个周期,其中3例配合放射治疗,观察1,3,5,10年生存率。结果1,3,5,10年生存率分别为68.6%(24/35)、45.7%(16/35)、31.4%(11/35)、16.7%(4/24)。分期比较5年生存率差异有统计学意义(P〈0.05);治疗周期比较1,3,5年生存率差异有统计学意义(P均〈0.01)。结论CHOP是目前治疗非霍奇金淋巴瘤较好的治疗方案,综合治疗疗效较好。

关 键 词:非霍奇金淋巴瘤  化学治疗  放射治疗  远期疗效

The long-term effect observation of CHOP chemotherapy on non-Hodgkin's lymphoma
Wei Bing , Liu Kuanrong.The long-term effect observation of CHOP chemotherapy on non-Hodgkin's lymphoma[J].Public Medical Forum Magazine,2012,16(17):2181-2182.
Authors:Wei Bing  Liu Kuanrong
Institution:.Yangcheng County Tumor Hospital,Yangcheng,Shanxi 048100
Abstract:Objective To study the long-term effect observation of CHOP chemotherapy on non-hodgkin’s lymphoma.Methods 35 cases of non-hodgkin’s lymphoma were treated with CHOP chemotherapy for 1~14 cycle.based the chemotherapy 3 cases undertook radiotherapy.weattreatment of the clinical data and were followed up the analysis.1,3,5 and 10 year survival rates were observed.Results 1,3,5 and 10 year survival rates were 65.7%(23/35),42.9%(15/35),28.6%(10/35),16.7%(4/24)respectively.Stage 5 years of survival rate is a statistically significant(P<0.05).There was statistically significant difference in treatment cycle 1,3,5 year’s survival rates(P<0.01).Conclusion CHOP is a better treatment for non-hodgkin’s lymphoma.
Keywords:Non-hodgkin’s lymphoma Chemotheropy Teletherapy The long-term outcome
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号